Prelude Capital Management’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,855
| Closed | -$11.1K | – | 1321 |
|
|
2024
Q2 | $11.1K | Sell |
1,855
-8,225
| -82% | -$49.4K | ﹤0.01% | 1084 |
|
|
2024
Q1 | $90.9K | Buy |
+10,080
| New | +$90.9K | ﹤0.01% | 1097 |
|
|
2023
Q3 | – | Sell |
-3,620
| Closed | -$88.7K | – | 1116 |
|
|
2023
Q2 | $88.7K | Buy |
3,620
+1,987
| +122% | +$48.7K | 0.01% | 824 |
|
|
2023
Q1 | $51.1K | Buy |
+1,633
| New | +$51.1K | ﹤0.01% | 906 |
|